News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Hidehito Horinouchi: iDFS reliably predicts final OS in breast cancer
Hidehito Horinouchi/X
Feb 7, 2025, 14:07

Hidehito Horinouchi: iDFS reliably predicts final OS in breast cancer

Hidehito Horinouchi, Assistant Chief of the National Cancer Center Hospital, shared a post on X about a recent paper by Fabio Conforti et al. published in the Journal of Clinical Oncology:

“Surrogate End Points for Overall Survival in Neoadjuvant Randomized Clinical Trials for Early Breast Cancer.

iDFS is an acceptable surrogate endpoint to confidently anticipate the final OS.

Dr. Fabio Conforti.”

“Surrogate End Points for Overall Survival in Neoadjuvant Randomized Clinical Trials for Early Breast Cancer”

Authors: Fabio Conforti, Valentina Nekljudova, Isabella Sala, Richard Gelber, Sibylle Loibl et al.

Hidehito Horinouchi: iDFS reliably predicts final OS in breast cancer

More posts featuring Hidehito Horinouchi.

Breast Cancer cancer Fabio Conforti Hidehito Horinouchi IDFS Isabella Sala OncoDaily Oncology Richard Gelber Sibylle Loibl Valentina Nekljudova
Special Coverage
Science
Feb 7, 2025, 14:07
Hidehito Horinouchi: iDFS reliably predicts final OS in breast cancer
Career
Feb 7, 2025, 14:03
Mohammad Jad Moussa: Honored to receive the 2025 ASCO GU Cancers Symposium Merit Award
Blog
Feb 7, 2025, 13:55
Mark Lawler: Highlighting the poor delivery of optimal cancer care in UK
Insight
Feb 7, 2025, 13:53
Samer Al Hadidi: A case of secondary T-cell lymphoma of the GI tract
Blog
Feb 7, 2025, 13:50
Submissions are open for the Research Course in Radiotherapy Physics - ESTRO
Blog
Feb 7, 2025, 13:48
Rob Winn: Celebrating 30 years of the incredible Women and Wellness event in Richmond
Blog
Feb 7, 2025, 13:45
Connecting with healthcare leaders transforming cancer care in the UAE region - Dana-Farber Cancer Institute
Blog
Feb 7, 2025, 13:39
Rawia Mohamed: Biomarkers in Gastroesophageal Cancer
Insight
Feb 7, 2025, 13:25
Adjuvant Atezolizumab for Early Triple-Negative Breast Cancer
Blog
Feb 7, 2025, 13:19
Yasser Mohamed Ali Ged: IO Combination Therapy for Metastatic MiT Family Translocation Renal Cell Carcinoma
Career
Feb 7, 2025, 13:18
Pfizer Announced Jeffrey Legos As Their New Chief Oncology Officer
Blog
Feb 7, 2025, 13:16
Kamila Naxerova: Quantifying cell divisions along evolutionary lineages in cancer